Difference between revisions of "CD56"

From Libre Pathology
Jump to navigation Jump to search
m (myeloma)
 
Line 12: Line 12:
*[[Extranodal NK/T-cell lymphoma, nasal type]].
*[[Extranodal NK/T-cell lymphoma, nasal type]].
*[[Hepatosplenic T-cell lymphoma]].
*[[Hepatosplenic T-cell lymphoma]].
*[[Plasma cell myeloma]]


===Others===
===Others===

Latest revision as of 22:39, 26 March 2021

CD56 is a commonly available immunostain that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation.

Positive

Carcinomas

Lymphoid

Others

Occasionally positive

See also

References

  1. Kurokawa, M.; Nabeshima, K.; Akiyama, Y.; Maeda, S.; Nishida, T.; Nakayama, F.; Amano, M.; Ogata, K. et al. (May 2003). "CD56: a useful marker for diagnosing Merkel cell carcinoma.". J Dermatol Sci 31 (3): 219-24. PMID 12727026.
  2. 2.0 2.1 URL: http://www.nordiqc.org/Epitopes/CD56/CD56.htm. Accessed on: September 13, 2014.
  3. Bahrami, A.; Gown, AM.; Baird, GS.; Hicks, MJ.; Folpe, AL. (Jul 2008). "Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.". Mod Pathol 21 (7): 795-806. doi:10.1038/modpathol.2008.86. PMID 18487991.
  4. Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P (May 2010). "Evaluation of neuroendocrine markers in renal cell carcinoma". Diagn Pathol 5: 28. doi:10.1186/1746-1596-5-28. PMC 2876076. PMID 20462442. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876076/.